Drug Screening Antibodies For Enzymes, Transcription Factors

Antibodies available for the pre-clinical drug development marketplace identify key enzymes and transcription factors important in drug metabolism and its regulation. This product platform enables safe drug compounds to be identified sooner and allows only the molecules most likely to succeed in the clinic to advance. Early compound identification makes it possible to reduce the development time for new therapies. Future co-development efforts will be focused on building predictive toxicity and drug metabolism screens to profile compounds in various cell based and in vitro assays.